Approval · Notice of Compliance 27316 · 2021
TEPADINA: Notice of Compliance 27316
Issued December 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27316
- Date
- December 30, 2021
- Company
- Adienne SaLugano, Tessin, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Nwe strength. new container closure system.convert product monograph to 2020 format. update to package insert and labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEPADINA | 02523906 | Dormant |
| TEPADINA | Not yet assigned | — |